With multiple clinical trials and approval applications in train, nuclear medicine superstar Telix Pharmaceuticals (ASX:TLX) is like one of those irritatingly brilliant all-round students.We’re thinking of the straight-A school captain who stars in the school play, whilst padding up for the First XI in between clarinet lessons.
https://**promotion blocked**/health/dr-borehams-crucible-telix-has-homework-but-remains-dux-of-radioimaging-class/
Dr Boreham’s Crucible: Telix has homework but remains dux of radioimaging class
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.60 |
Change
-0.350(2.34%) |
Mkt cap ! $4.940B | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.44 | $14.57 | $95.65M | 6.420M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 6765 | $14.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.65 | 4128 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2025 (20 minute delay) ? |
| TLX (ASX) Chart |